Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Disease in Infants: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background & Objective: Respiratory syncytial virus (RSV) continues to be a leading cause of lower respiratory tract disease and hospitalization during infancy. With newer long-acting monoclonal antibodies, including clesrovimab, an updated synthesis of randomized evidence is required to define overall efficacy and saf...